DYNE THERAPEUTICS, INC.

Lobbying client · Massachusetts · filed 2026 to 2026

A biotechnology company developing nucleic acid therapies for rare diseases.

$80,000 Reported spend

3 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page comes from one LDA client record (72232), filed by the registrant listed below.

Who filed for this client 1

W STRATEGIES, LLC $80,000 Outside firm · 3 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 1 year

2026 $80,000 3 filings

Issues lobbied 1

Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 1

Recent filings 3 total

Q3 report

W STRATEGIES, LLC

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 19, 2026

View → Q2 report

W STRATEGIES, LLC

2nd Quarter 2026 (Apr 1 - June 30) · House · $40,000 income · posted Jul 20, 2026

View → Registration

W STRATEGIES, LLC

2nd Quarter 2026 (Apr 1 - June 30) · posted Apr 7, 2026

View →

Keep going

Filings through October 19, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.